Antabio: Clinical Trials

3 trials sponsored by Antabio, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow Antabio: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants
ANT3310, Meropenem - Pharmacokinetics Study on Healthy Volunteers Adults
Phase 1CompletedAntabio262025-04-282025-10-02
Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects
ANT3310, Meropenem - Renal Impairment
Phase 1CompletedAntabio412024-07-192025-07-29
FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects
ANT3310, ANT3310-placebo, Meropenem - Healthy Volunteers
Phase 1CompletedAntabio722023-04-122024-03-15

Conditions studied

Renal Insufficiency (1)

Interventions

Meropenem (3)

Countries

France (1)  ·  Germany (1)  ·  United States (1)

Top investigators

Christian Zwingelstein, PharmD (1)  ·  J. Burr Ross, MD (1)  ·  Sophie Hays, MD (1)